LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
- PMID: 33784890
- PMCID: PMC8020091
- DOI: 10.1177/15330338211004944
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
Abstract
Background and objective: Gastric cancer (GC) is a common tumor malignancy with high incidence and poor prognosis. Laminin is an indispensable component of basement membrane and extracellular matrix, which is responsible for bridging the internal and external environment of cells and transmitting signals. This study mainly explored the association of the LAMB1 expression with clinicopathological characteristics and prognosis in gastric cancer.
Methods: The expression data and clinical information of gastric cancer patients were downloaded from The Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG). And we analyzed the relationship between LAMB1 expression and clinical characteristics through R. CIBERSORTx was used to calculate the absolute score of immune cells in gastric tumor tissues. Then COX proportional hazard models and Kaplan-Meier curves were performed to evaluate the role of LAMB1 and its influence on prognosis in gastric cancer patients. Finally, GO and KEGG analysis were applied for LAMB1-related genes in gastric cancer, and PPI network was constructed in Cytoscape software.
Results: In the TCGA cohort, patients with gastric cancer frequently generated LAMB1 gene copy number variation, but had little effect on mRNA expression. Both in the TCGA and ACRG cohorts, the mRNA expression of LAMB1 in gastric cancer tissues was higher than it in normal tissues. All patients were divided into high expression group and low expression group according to the median expression level of LAMB1. The elevated expression group obviously had more advanced cases and higher infiltration levels of M2 macrophages. COX proportional hazard models and Kaplan-Meier curves revealed that patients with enhanced expression of LAMB1 have a worse prognosis. GO/KEGG analysis showed that LAMB1-related genes were enriched in PI3K-Akt signaling pathway, focal adhesion, ECM-receptor interaction, etc.
Conclusions: The high expression of LAMB1 in gastric cancer is related to the poor prognosis of patients, and it may be related to microenvironmental changes in tumors.
Keywords: CIBERSORTx; GC; LAMB1; TICs; TME; gastric cancer; prognosis; survival; the β1 subunit of laminin; therapeutic target; tumor microenvironment; tumor-infiltrating immune cells.
Conflict of interest statement
Figures
Similar articles
-
Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.Biomed Res Int. 2021 Aug 9;2021:6428873. doi: 10.1155/2021/6428873. eCollection 2021. Biomed Res Int. 2021. PMID: 34414238 Free PMC article.
-
Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.Int J Mol Sci. 2021 Jan 10;22(2):626. doi: 10.3390/ijms22020626. Int J Mol Sci. 2021. PMID: 33435161 Free PMC article.
-
RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820970684. doi: 10.1177/1533033820970684. Technol Cancer Res Treat. 2020. PMID: 33176601 Free PMC article.
-
Genomic alterations and molecular subtypes of gastric cancers in Asians.Chin J Cancer. 2016 May 9;35:42. doi: 10.1186/s40880-016-0106-2. Chin J Cancer. 2016. PMID: 27160712 Free PMC article. Review.
-
The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer.Biomed Res Int. 2018 Feb 27;2018:3201940. doi: 10.1155/2018/3201940. eCollection 2018. Biomed Res Int. 2018. PMID: 29682534 Free PMC article. Review.
Cited by
-
Proteomic Analyses of the G Protein-Coupled Estrogen Receptor GPER1 Reveal Constitutive Links to Endoplasmic Reticulum, Glycosylation, Trafficking, and Calcium Signaling.Cells. 2023 Nov 3;12(21):2571. doi: 10.3390/cells12212571. Cells. 2023. PMID: 37947649 Free PMC article.
-
Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.PeerJ. 2023 Oct 16;11:e16243. doi: 10.7717/peerj.16243. eCollection 2023. PeerJ. 2023. PMID: 37868053 Free PMC article.
-
HIF1A overexpression predicts the high lymph node metastasis risk and indicates a poor prognosis in papillary thyroid cancer.Heliyon. 2023 Mar 17;9(3):e14714. doi: 10.1016/j.heliyon.2023.e14714. eCollection 2023 Mar. Heliyon. 2023. PMID: 36994412 Free PMC article.
-
Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.Biomolecules. 2023 Feb 9;13(2):339. doi: 10.3390/biom13020339. Biomolecules. 2023. PMID: 36830707 Free PMC article.
-
Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1.Int J Environ Res Public Health. 2023 Jan 27;20(3):2283. doi: 10.3390/ijerph20032283. Int J Environ Res Public Health. 2023. PMID: 36767649 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492 - PubMed
-
- Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet Lond Engl. 2016;388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-3 - PubMed
-
- Hecht JR, Bang Y-J, Qin SK, et al. Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013/LOGiC—a randomized phase III trial. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(5):443–451. doi:10.1200/JCO.2015.62.6598 - PubMed
-
- Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs. 2012;30(4):1684–1689. doi:10.1007/s10637-011-9736-z - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
